Immunohistochemical expression of phospho-Akt in uveal melanoma
Authors:
- Vinicius S. SaraivaVSVinicius S. Saraiva
- Amanda L. CaissieACAmanda L. Caissie
- Laura SegalLSLaura Segal
- Chaim EdelsteinCEChaim Edelstein
- Miguel N. BurnierMBMiguel N. Burnier
- 1 August 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 15 (4) , 245-250
Abstract
The aim of this study was to evaluate the immunohistochemical expression of phospho-Akt and its possible association with clinicopathological features in uveal melanoma. Thirty-four enucleated eyes from 34 patients with choroidal melanoma were included in the study. Patients were divided into two groups based on the treatment received: (1) primary enucleation (n=18); (2) radiotherapy, either external beam or brachytherapy, and enucleation (n=16). Clinicopathological data were obtained. The minimum follow-up time was 72 months. Immunohistochemistry for phospho-Akt was performed using an anti-phospho-Akt (Ser 473) rabbit antibody. The association of phospho-Akt with clinicopathological parameters was investigated in each patient group separately. Phospho-Akt immunostaining was cytoplasmic in both groups. In the primary enucleation group, 10 tumours were phospho-Akt positive (55.5%). Patients with phospho-Akt-positive tumours were older (average 70.8 years versus 59 years, P=0.01) and phospho-Akt immunoreactivity was significantly associated with a higher risk of metastatic disease (Kaplan–Meier analysis, P=0.02). In the radiotherapy and enucleation group, nine tumours were phospho-Akt positive (56.2%). The absence of phospho-Akt expression was correlated with male gender (P=0.02). The following conclusions can be drawn from this study: (1) phospho-Akt immunoexpression was detected in 55.5% of uveal melanomas treated with primary enucleation and in 56.2% of uveal melanomas treated with radiotherapy and enucleation; (2) the association of phospho-Akt immunoexpression with clinicopathological features, including prognosis, merits further study.Keywords
This publication has 32 references indexed in Scilit:
- Survival rates with uveal melanoma in the United States: 1973–1997Ophthalmology, 2003
- Management of Posterior Uveal Melanoma: Past, Present, FutureRetina, 2002
- Interleukin 3-dependent survival by the Akt protein kinaseProceedings of the National Academy of Sciences, 1997
- The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.Genes & Development, 1997
- Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKBNature, 1997
- Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase AktScience, 1997
- The biology of haematogenous metastasis in human meal malignant melanomaVirchows Archiv, 1993
- Prognosis and treatment of disseminated uveal melanomaCancer, 1993
- Epidemiologic aspects of uveal melanomaSurvey of Ophthalmology, 1988
- Survival in metastatic ocular melanomaCancer, 1983